Common Contracts
3 similar Common Stock Purchase Warrant contracts by Spring Bank Pharmaceuticals, Inc., Arqule Inc
AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT SPRING BANK PHARMACEUTICALS, INC.Common Stock Purchase Warrant • April 13th, 2020 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT (the “Warrant”) amends and restates, in its entirety, that certain Warrant for the purchase of up to [______] shares of the Common Stock (the “Warrant Shares”) of Spring Bank Pharmaceuticals, Inc., a Delaware corporation (the “Company”), issued to Pontifax Medison Finance ([Israel][Cayman]) L.P. or its assigns (the “Holder”), on September 19, 2019 (the “2019 Warrant”). The Holder is the holder of the 2019 Warrant, and the Holder, by its signature below, hereby agrees to the changed terms as set forth herein. This Warrant is being issued in consideration for the Lender Parties’ consent to a reduced Prepayment Charge and shorter period for the Prepayment Notice, as set forth in that certain Prepayment Notice and Payoff Letter dated as of April 8, 2020.
COMMON STOCK PURCHASE WARRANT SPRING BANK PHARMACEUTICALS, INC.Common Stock Purchase Warrant • November 1st, 2019 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Pontifax Medison Finance ( ) L.P. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time prior to the close of business on the sixth-year anniversary of the Closing Date (as defined in the Loan Agreement)2 (such 6th anniversary, the “Termination Date”) but not thereafter, to subscribe for and purchase from Spring Bank Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ___ shares of Common Stock (the “Warrant Shares”). The purchase price for each Warrant Share shall be equal to the Exercise Price as defined in Section 2(d).
COMMON STOCK PURCHASE WARRANT ARQULE, INC.Common Stock Purchase Warrant • October 16th, 2017 • Arqule Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October [•], 2017 (the “Initial Exercise Date”) and on or prior to the close of business on the fourth-year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from ArQule, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
